InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

16.38
Delayed Data
As of Apr 17
 -0.47 / --
Today’s Change
1.86
Today|||52-Week Range
19.68
+210.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization144.7K366.9K740.7K752.0K
 
 
 
 
 
 
Operating ExpensesGross Income-144.7K-366.9K-740.7K-752.0K
 
 
 
 
 
General Expenses8.5M12.4M18.3M17.1M
 
 
 
 
 
Research And Development4.1M6.4M10.5M10.3M
 
 
 
 
 
Total Operating Expenses8.7M12.8M19.0M17.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.7M-12.8M-19.0M-17.8M
 
 
 
 
 
Extraordinary Credit0.0017.5M----
 
 
Extraordinary Charge-26.1M0.00-19.6M-376.0K
 
 
 
 
Interest Expense On Debt16.7K71.7K129.9K136.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.7M4.7M-38.8M-18.3M
 
 
 
 
 
Net Income-34.7M4.7M-38.8M-18.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.0M15.8M18.5M22.1M
 
 
 
 
 
Shares To Calculate EPS Diluted13.0M18.0M18.5M22.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.68$0.24-$2.08-$0.84
 
 
 
 
 
EPS Diluted-$2.68$0.24-$2.08-$0.84
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account